Literature DB >> 26085723

A Cross-Sectional Study on Burden of Hepatitis C, Hepatitis B, HIV and Syphilis in Multi-Transfused Thalassemia Major Patients Reporting to a Government Hospital of Central India.

Shrivastava Manisha1, Kumar Sanjeev2, Navaid Seema1, Chotrani Dilip3, Dwivedi Rashmi4.   

Abstract

Need for frequent blood transfusions exposes thalassemia major patients to risk of transfusion-transmitted infections (TTIs). Screening of donor blood through national protocols for possible infections like hepatitis B and C, HIV, syphilis and malaria is considered the optimal preventive method. There is constant need to explore the effect of currently used protocols of blood-donor screening by determining the burden of TTIs in multi-transfused patients. The current study was conducted to determine the burden of TTIs among multi-transfused Thalassemia patients registered at a Government hospital of central India. Sixty-six multi-transfused Thalassemia patients reporting during a period of eight months were screened for hepatitis B and C, HIV as well as syphilis by using standard diagnostic tests. Selected clinical, socio-demographic and other characteristics were also recorded to understand the determinants of risks of these infections. The sero-prevalence of hepatitis B, hepatitis C, HIV and syphilis was 3.0, 18.2, 1.5 and 0 % respectively amongst the patients. Vaccination against hepatitis B was found to be protective. Majority of the infected patients had history of transfusion from non government blood banks. There is a considerable burden of Hepatitis C among multi-transfused Thalassemia patients. The currently used screening tests need to be revalidated or replaced to prevent false-negative diagnoses. All sectors need to optimally implement and control both, the quality of blood donors and the mandatory screening of blood and blood products against the TTIs along with prospective longitudinal data and follow up of patients.

Entities:  

Keywords:  Blood-transfusion; Burden; Screening tests; Seroprevalence; Thalassemia

Year:  2014        PMID: 26085723      PMCID: PMC4465515          DOI: 10.1007/s12288-014-0462-5

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  26 in total

Review 1.  Transfusion safety in developing countries and the Indian scenario.

Authors:  V L Ray; R K Chaudhary; N Choudhury
Journal:  Dev Biol (Basel)       Date:  2000

2.  Kuppuswamy's socioeconomic status scale-updating for 2007.

Authors:  N Kumar; C Shekhar; P Kumar; A S Kundu
Journal:  Indian J Pediatr       Date:  2007-12       Impact factor: 1.967

3.  Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital.

Authors:  K Chatterjee; P Coshic; M Borgohain; R M Thapliyal; S Chakroborty; S Sunder
Journal:  Natl Med J India       Date:  2012 Jul-Aug       Impact factor: 0.537

4.  Blood transfusion transmitted infections in multiple blood transfused patients of Beta thalassaemia.

Authors:  Prakash J Vidja; J H Vachhani; S S Sheikh; P M Santwani
Journal:  Indian J Hematol Blood Transfus       Date:  2011-04-11       Impact factor: 0.900

5.  Common transfusion-transmitted infectious agents among thalassaemic children in Bangladesh.

Authors:  Abid Hossain Mollah; Nazmun Nahar; Md A Siddique; Kazi Selim Anwar; Tariq Hassan; Md Golam Azam
Journal:  J Health Popul Nutr       Date:  2003-03       Impact factor: 2.000

6.  Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.

Authors:  R N Makroo; N Choudhury; L Jagannathan; M Parihar-Malhotra; V Raina; R K Chaudhary; N Marwaha; N K Bhatia; A K Ganguly
Journal:  Indian J Med Res       Date:  2008-02       Impact factor: 2.375

7.  Frequency of hepatitis B, C and D and human immunodeficiency virus infections in multi-transfused thalassemics.

Authors:  D N Amarapurkar; A Kumar; S Vaidya; P Murti; S K Bichile; R H Kalro; H G Desai
Journal:  Indian J Gastroenterol       Date:  1992-04

8.  Hepatitis C virus antibodies and other markers of blood-transfusion-transmitted infection in multi-transfused Cuban patients.

Authors:  José M Ballester; René A Rivero; Rinaldo Villaescusa; Julio C Merlín; Ada A Arce; Dunia Castillo; Rosa M Lam; Adalberto Ballester; Miguel Almaguer; Silvia M Melians; José L Aparicio
Journal:  J Clin Virol       Date:  2005-12       Impact factor: 3.168

9.  Prevalence of anti HCV infection in patients with Beta-thalassemia in isfahan-iran.

Authors:  Behrooz Ataei; Marjan Hashemipour; Nazila Kassaian; Razieh Hassannejad; Zary Nokhodian; Peyman Adibi
Journal:  Int J Prev Med       Date:  2012-03

10.  Need for nucleic Acid testing in countries with high prevalence of transfusion-transmitted infections.

Authors:  Rohit Jain; Pankaj Aggarwal; Gajendra Nath Gupta
Journal:  ISRN Hematol       Date:  2012-09-12
View more
  6 in total

1.  Seroprevalence of HBV, HCV and HIV-1 and Correlation with Molecular Markers among Multi-Transfused Thalassemia Patients in Western India.

Authors:  Kanchan Mishra; Avani Shah; Krima Patel; Kanjaksha Ghosh; Sumit Bharadva
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-07-01       Impact factor: 2.576

2.  Seroprevalence of Hepatitis C, Hepatitis B, Cytomegalovirus, and Human Immunodeficiency Viruses in Multitransfused Thalassemic Children in Upper Egypt.

Authors:  Ramadan A Mahmoud; Abdel-Azeem M El-Mazary; Ashraf Khodeary
Journal:  Adv Hematol       Date:  2016-02-17

3.  Evaluation of hepatitis C, hepatitis B, and HIV virus Serology pandemic in thalassemia patients of Shahid Mohammadi Hospital of Bandar Abbas, Iran.

Authors:  Mohammad Aminianfar; Farrokh Khani; Iman Ghasemzadeh
Journal:  Electron Physician       Date:  2017-03-25

4.  Clinical and Metabolic Complications in patients with thalassemia undergoing transfusion therapy.

Authors:  Babita Raghuwanshi; Suchitra Kumari; Durgesh Prasad Sahoo
Journal:  J Family Med Prim Care       Date:  2020-02-28

5.  Menace of Hepatitis C virus among multitransfused thalassemia patients in Balasore district of Odisha state in India.

Authors:  Mithilesh K Sinha; Babita Raghuwanshi; Bijayanimala Mishra
Journal:  J Family Med Prim Care       Date:  2019-09-30

6.  Safety and Efficacy of Sofosbuvir and Daclatasvir for Hepatitis C Virus Infection in Patients with β-Thalassemia Major.

Authors:  Rajiv Mehta; Mayank Kabrawala; Subhash Nandwani; Pankaj Desai; Vishwa Bhayani; Sanjay Patel; Viral Parekh
Journal:  J Clin Exp Hepatol       Date:  2017-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.